# OnCo record nct06532006 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06532006/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06532006", "NCT06532006" ;
  schema:name "A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer"@en ;
  schema:description "A phase 3 trial testing HLX22 in gastric & gastro-oesophageal junction cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06532006/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06532006> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-11-22" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/gastric-her2-positive/> ;
  onco:drugs <https://onco.cc/drugs/hlx22/> ;
  onco:companies <https://onco.cc/companies/henlius/> .
